Listen: Orthocell Is Pioneering Suture-less Repair Of Soft Tissue


In a recent statement, the regenerative medicine company Orthocell is proud to announce their patent for “Suture-less Repair of Soft Tissue” has gone through. This of course refers to the method repairing damaged soft tissue without needing to stitch the wound shut. It’s an exciting time to be in the medical world as Managing Director of Orthocell, Paul Anderson had this to say, “This is an important addition to our current global IP portfolio. Not only does it further strengthen our IP position in regenerative medicine products and surgical techniques for soft tissue repair, but it also acts to validate CelGro as a collagen medical device platform. The company believes that this innovation has the potential to offer a wider application range in existing markets like bones, tendons, nerves, and even cartilage reconstruction. Looks to me like this is an exciting day for the medical field!

Follow us on social media for the latest updates in B2B!


Improving Quality and Bottomline for Finishing Operations
June 30, 2022
This is another episode of Manufacturing A Stronger Standard from FABTECH 2021. Host and President of Lesta USA and Degeest Corp., Derek Degeest, talked with Bill Robinson, President and Kris Bonnegent, Regional Read more
Adapting Existing and New Wagner Solutions to Leverage Self-Learning Robots
June 30, 2022
This episode of Manufacturing A Stronger Standard was live from FABTECH 2021. Host and President of LestaUSA and DeGeest Corp., Derek DeGeest, talked with JR Rogers, National Sales Manager for Engineered Systems Read more
How to Be Your Own Healthcare Advocate
June 30, 2022
While healthcare in the United States is often the topic of a heated political debate, there is one subject within it that irks patients and healthcare practitioners alike: time. One of the biggest problems with Read more